NCT02945046 · Interventional trial
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Overall registry status Terminated
Phase 3
Conditions Episodic Cluster Headache
Delaware Valley sites
- Teva Investigational Site 13824 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory